Lipitor

Pfizer 4Q net falls by half after generic Lipitor

Pfizer 4Q net falls by half after generic Lipitor

Yahoo/AP

Express Scripts Will Make Changes to Lipitor Coverage

Express Scripts Will Make Changes to Lipitor Coverage

WSJ Online

Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says

Pfizer’s Lipitor Plan Might Not Be ‘Worth It,’ Watson CEO Says

Bloomberg

Pfizer Suffering from Withdrawal Symptoms

Pfizer Suffering from Withdrawal Symptoms

Motley Fool

Sales of Lipitor Are Leveling Off

Sales of Lipitor Are Leveling Off

New York Times

Sales of Lipitor Are Leveling Off

Sales of Lipitor Are Leveling Off

NY Times, NY

Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says

Pfizer’s Share of Lipitor Market Will Continue to Fall, Watson CEO Says

Bloomberg

Let Pfizer Compete in the Generic Market with Lipitor

Let Pfizer Compete in the Generic Market with Lipitor

Pharmareform

Pfizer In A Post-Lipitor World: Worth Buying On Dips

Pfizer In A Post-Lipitor World: Worth Buying On Dips

Seeking Alpha

Lipitor And Strategic Collapse At Pfizer

Lipitor And Strategic Collapse At Pfizer

Seeking Alpha